Generic placeholder image

Current Aging Science

Author(s): Santhi Priya Sobha and Kumar Ebenezar Kesavarao*

DOI: 10.2174/1874609815666220304193925

DownloadDownload PDF Flyer Cite As
Contribution of Glutathione-S-Transferases Polymorphism and Risk of Coronary Artery Diseases: A Meta-Analysis

Page: [282 - 292] Pages: 11

  • * (Excluding Mailing and Handling)

Abstract

Background: Oxidative stress is one of the risk components in the development of coronary artery diseases (CAD). Genetic polymorphism in major antioxidant genes like Glutathione- S-Transferases (GST) has been associated with increased CAD susceptibility and severity.

Objective: To get a precise evaluation and to update the association, a meta-analysis on GST (GSTM1, GSTT1, and GSTP1) polymorphism with CAD was performed. Moreover, the combined effect of GSTM1/GSTT1 null genotypes on CAD risk has not yet been studied, but it has the highest risk of developing diseases.

Materials and Methods: PubMed, Embase, and Web of Science were systematically searched for eligible studies. Case-control studies in the English language and with genotypic frequency were selected in order to provide data and calculate the odds ratio (OR). OR with 95% CI was calculated, and a random effect model was used. NOS scale was used to assess the quality of the included studies.

Results: Meta-analysis indicated that the GSTM1 null genotype and GSTP1 (Ile105Val) polymorphism is significantly associated with CAD risk with a pooled OR-1.38, p=0.01 for GSTM1 and OR-1.19, p=0.04 for GSTP1. The dual null genotype of GSTM1-GSTT1 has the highest risk for CAD development (OR-1.59, p=0.003), and there is no significant association between GSTT1 null genotype with CAD. In the subgroup analysis, GSTM1 showed an increased risk for Asians (OR- 1.68, p=<0.01) and smokers (OR-1.98, p=<0.01). Publication bias was not observed.

Conclusion: The findings suggest that the GSTM1 and GSTP1 polymorphism can be a predictive factor for CAD risk, and a larger sample size is required further to confirm the association.

Keywords: CAD, GST, gene polymorphism, ethnicity, smoking, meta-analysis, glutathione-s-transferases.

Graphical Abstract

[1]
WHO. WHO | Cardiovascular diseases (CVDs) 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
[2]
Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol 2016; 8(1): 1-23.
[http://dx.doi.org/10.4330/wjc.v8.i1.1 ] [PMID: 26839654]
[3]
Aggarwal A, Srivastava S, Velmurugan M. Newer perspectives of coronary artery disease in young. World J Cardiol 2016; 8(12): 728-34.
[http://dx.doi.org/10.4330/wjc.v8.i12.728 ] [PMID: 28070240]
[4]
Martinez PF, Okoshi MP. Genetic risk in coronary artery disease. Arq Bras Cardiol 2018; 111(1): 62-3.
[PMID: 30110045]
[5]
Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 1981; 33(1): 36-43.
[PMID: 7468592]
[6]
Dusinská M, Ficek A, Horská A, et al. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res 2001; 482(1-2): 47-55.
[http://dx.doi.org/10.1016/S0027-5107(01)00209-3 ] [PMID: 11535248]
[7]
Song Y, Shan Z, Liu X, et al. An updated meta-analysis showed smoking modify the association of GSTM1 null genotype on the risk of coronary heart disease. Biosci Rep 2021; 41(2)BSR20200490
[http://dx.doi.org/10.1042/BSR20200490 ] [PMID: 33506866]
[8]
Su H, Cao Y, Li J, Zhu Y, Ma X. GST null polymorphisms may affect the risk of coronary artery disease: evidence from a meta-analysis. Thromb J 2020; 18(1): 20.
[http://dx.doi.org/10.1186/s12959-020-00234-x ] [PMID: 32905149]
[9]
Israel H, Richter RR. A guide to understanding meta-analysis. J Orthop Sports Phys Ther 2011; 41(7): 496-504.
[http://dx.doi.org/10.2519/jospt.2011.3333 ] [PMID: 21725192]
[10]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629 ] [PMID: 9310563]
[11]
Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet 2006; 7(1): 38-45.
[http://dx.doi.org/10.1186/1471-2350-7-38 ] [PMID: 16620396]
[12]
Bazo AP, Salvadori D Jr, Salvadori RAF, et al. DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease. Cardiovasc Pathol 2011; 20(1): e9-e15.
[http://dx.doi.org/10.1016/j.carpath.2009.12.004 ] [PMID: 20093049]
[13]
Bhat MA, Gandhi G. Association of GSTT1 and GSTM1 gene polymorphisms with coronary artery disease in North Indian Punjabi population: A case-control study. Postgrad Med J 2016; 92(1094): 701-6.
[http://dx.doi.org/10.1136/postgradmedj-2015-133836 ] [PMID: 27215231]
[14]
Bhatti JS, Vijayvergiya R, Singh B, Bhatti GK. Genetic susceptibility of glutathione S-transferase genes (GSTM1/T1 and P1) to coronary artery disease in Asian Indians. Ann Hum Genet 2018; 82(6): 448-56.
[15]
Girisha KM, Gilmour A, Mastana S, et al. T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci 2004; 58(12): 520-6.
[PMID: 15627678]
[16]
Hayek T, Stephens JW, Hubbart CS, et al. A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 2006; 184(2): 404-12.
[http://dx.doi.org/10.1016/j.atherosclerosis.2005.05.017 ] [PMID: 16002077]
[17]
Kadıoğlu E, Taçoy G, Özçağlı E, et al. The role of oxidative DNA damage and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery disease risk. Anatol J Cardiol 2016; 16(12): 931-8.
[http://dx.doi.org/10.14744/AnatolJCardiol.2016.6697] [PMID: 27182613]
[18]
Manfredi S, Calvi D, del Fiandra M, Botto N, Biagini A, Andreassi MG. Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogeno 2009; 10(1): 29-34.
[http://dx.doi.org/10.2217/14622416.10.1.29 ] [PMID: 19102712]
[19]
Martin NJ, Collier AC, Bowen LD, et al. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutat Res 2009; 674(1-2): 93-100.
[http://dx.doi.org/10.1016/j.mrgentox.2008.09.009 ] [PMID: 18950733]
[20]
Masetti S, Botto N, Manfredi S, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med (Berl) 2003; 81(8): 488-94.
[http://dx.doi.org/10.1007/s00109-003-0448-5 ] [PMID: 12811412]
[21]
Mir R, Bhat MA, Javaid J, et al. Glutathione S-transferase M1 and T1 (rs4025935 and rs71748309) null genotypes are associated with increased susceptibility to coronary artery disease in Indian populations. Acta Cardiol 2016; 71(6): 678-84.
[http://dx.doi.org/10.1080/AC.71.6.3178186 ] [PMID: 27920455]
[22]
Nomani H, Mozafari H, Ghobadloo SM, et al. The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran. Mol Cell Biochem 2011; 354(1-2): 181-7.
[http://dx.doi.org/10.1007/s11010-011-0817-2 ] [PMID: 21499713]
[23]
Phulukdaree A, Khan S, Moodley D, Chuturgoon AA. GST polymorphisms and early-onset coronary artery disease in young South African Indians. S Afr Med J 2012; 102(7): 627-30.
[http://dx.doi.org/10.7196/SAMJ.5520 ] [PMID: 22748443]
[24]
Pourkeramati A, Mehrjardi Zare E, Tezerjani Dehghan M, Seifati SM. Association of GSTP1, GSTT1 and GSTM1 Gene Variants with Coronary Artery Disease in Iranian Population: A Case-Control Study. Int J Gen Med 2020; 13: 249-59.
[http://dx.doi.org/10.2147/IJGM.S252552 ] [PMID: 32547167]
[25]
Ramprasath T, Murugan Senthil P, Prabakaran AD, Gomathi P, Rathinavel A, Selvam GS. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun 2011; 407(1): 49-53.
[http://dx.doi.org/10.1016/j.bbrc.2011.02.097 ] [PMID: 21352813]
[26]
Syed R, Deeba F, Jamil K. Role of GSTM1 Gene polymorphism and its association with Coronary Artery Disease. J Clinical MedRes 2010; 22: 022-5.
[27]
Tamer L, Ercan B, Camsari A, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 2004; 99(3): 223-9.
[http://dx.doi.org/10.1007/s00395-004-0465-8 ] [PMID: 15088107]
[28]
Taspinar M, Aydos S, Sakiragaoglu O, et al. Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA Cell Biol 2012; 31(2): 211-8.
[http://dx.doi.org/10.1089/dna.2011.1252 ] [PMID: 21848428]
[29]
Wang LS, Tang JJ, Tang NP, et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin Chem Lab Med 2008; 46(12): 1720-5.
[http://dx.doi.org/10.1515/CCLM.2008.353 ] [PMID: 19055448]
[30]
Wang XL, Grecoa M, Sima AS, Duartea N, Wang J, Wilckena DEL. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J Cardiovas risk 2002; 9: 25-3.
[31]
Wilson MH, Grant PJ, Kain K, Warner DP, Wild CP. Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 2003; 8(1): 43-50.
[http://dx.doi.org/10.1080/1354750021000042439 ] [PMID: 12519635]
[32]
Yeh HL, Kuo LT, Sung FC, Chiang CW, Yeh CC. GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan. Gene 2013; 523(1): 64-9.
[http://dx.doi.org/10.1016/j.gene.2013.02.052 ] [PMID: 23570881]
[33]
Decharatchakul N, Settasatian C, Settasatian N, et al. Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease. Heart Vessels 2020; 35(7): 918-29.
[http://dx.doi.org/10.1007/s00380-020-01564-6 ] [PMID: 32034489]
[34]
Lakshmi SV, Naushad SM, Saumya K, Rao DS, Kutala VK. Role of CYP1A1 haplotypes in modulating susceptibility to coronary artery disease. Indian J Biochem Biophys 2012; 49(5): 349-55.
[PMID: 23259321]